Castle Biosciences Financial Overview
Castle Biosciences's market cap is currently $1.11B. The company's EPS TTM is $-0.02; its P/E ratio is ―; Castle Biosciences is scheduled to report earnings on November 3, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
